3 research outputs found
Atrial fibrillation recurrence prevention after electrical cardioversion in high-risk patients ā benefits of non-antiarrhythmic drugs
Publisher Copyright: Ā© 2021 Kokina et al.Background: Recurrence prevention after Atrial Fibrillation (AF) termination by Eelectrical Cardioversion (ECV) remains challenging. Increasing attention is paid to pathophysiological effects of non-Antiarrhythmic Drugs (non-AADs), nevertheless, with heterogeneous results. Objective: We evaluated the potential benefits of different non-AADs as adjunctive therapy to Antiarrhythmic Drugs (AADs) for AF recurrence prevention after sinus rhythm restoration by ECV in high-risk patients. Methods: The study was conducted among high-risk AF patients after successful ECV. Prescription of class IC or class III AAD was required. Data were acquired in a face-to-face baseline interview and 1-, 3-, 6-, 9-, 12-month follow-up interviews. Results: 113 patients were included. Total AF recurrence rate reached 48.7%. Angiotensin-Converting Enzyme Inhibitor (ACEI) or angiotensin receptor blocker (ARB) intake, compared with non-use, demonstrated AF recurrence rate reduction by 8.5% (46.3 vs. 54.8%), with odds ratio (OR) reduced by 28.9% (OR 0.711, 95% confidence interval (CI) 0.310-1.631, p = 0.420). Among mineralocorticoid receptor antagonist (MRA) users, AF recurrence rate was reduced by 25.1% (29.6 vs. 54.7%) and OR by 65.1% (OR 0.349, 95%CI 0.138-0.884, p = 0.023). Present statin therapy reduced AF recurrence rate by 4.2% (46.8 vs. 51.0%) and OR by 15.5% (OR 0.845, 95%CI 0.402-1.774, p = 0.656). Diuretic use showed reduction of AF recurrence rate by 10.2% (41.7 vs. 51.9%) and OR by 33.9% (OR 0.661, 95%CI 0.297-1.469, p = 0.308). Conclusion: Non-AADs demonstrated practical benefits as adjunctive therapy to AADs for AF recurrence prevention after ECV in high-risk patients, with statistically significant results established for concomitant MRA intake.publishersversionPeer reviewe
Ultra-performance liquid chromatography ā hybrid quadrupole ā linear trap mass spectrometry method for determining ochratoxin A in coffee
Augsti efektÄ«vÄs Ŕķidruma hromatogrÄfijas ā daudzpakÄpju kvadrupola masspektrometrijas metodes izstrÄde ohratoksÄ«na A noteikÅ”anai kafijÄ. Kokina Aija, zinÄtniskie vadÄ«tÄji: Dr. Ä·Ä«m., asoc. prof. Vadims BartkeviÄs, Mg. Ä·Ä«m., doktorante Iveta Pugajeva. MaÄ£istra darbs, 42 lappuses, 14 attÄli, 11 tabulas, 28 literatÅ«ras avoti. LatvieÅ”u valodÄ.
LiteratÅ«ras apskatÄ apkopota informÄcija (laika periodÄ no 1971. lÄ«dz 2015. gadam) par ohratoksÄ«nu A, tÄ veidoÅ”anÄs apstÄkļiem pÄrtikas produktos, par paraugu sagatavoÅ”anas metodÄm un ohratoksÄ«na A noteikÅ”anas iespÄjÄm, izmantojot augsti efektÄ«vo Ŕķidruma hromatogrÄfiju ā masspektrometriju, kÄ arÄ« OTA maksimÄli pieļaujamÄs normas pÄrtikas produktos.
PraktiskajÄ daÄ¼Ä tika izstrÄdÄta AEÅ H-MS/MS/MS metode ohratoksÄ«na A noteikÅ”anai kafijÄ un tÄ ir salÄ«dzinÄta ar citÄm OTA noteikÅ”anas metodÄm. IzstrÄdÄtÄ AEÅ H-MS/MS/MS metode tika pielietota OTA analÄ«zei Latvijas tirgÅ« pieejamajai kafijai. IzstrÄdÄtÄ metode tika validÄta uz sekojoÅ”iem parametriem - selektivitÄte, linearitÄte, matricas efekts, atgÅ«stamÄ«ba un precizitÄte, kÄ arÄ« noteikta detektÄÅ”anas un kvantificÄÅ”anas robeža.Ultra-performance liquid chromatography ā hybrid quadrupole ā linear trap mass spectrometry method for determining ochratoxin A in coffee. Kokina Aija, scientific leaders: Dr. chem., asoc. prof. Vadims BartkeviÄs, Mg. chem., doctoral student Iveta Pugajeva. Course work, 42 pages, 14 pictures, 11 tables, 28 literature sources. Latvian language.
In literature review the information dated from 1997 to 2015 regarding ochratoxin A has been summarized. The literature review included the following topics: formation conditions in the food products, sample preparation methods and ochratoxin A detection capabilities using high-performance liquid chromatography - mass spectrometry, as well as maximum levels for this contaminant in foodstuffs.
The practical part included the development of the UPLC-MS/MS/MS method for determination of ochratoxin A in coffee and comparison with other OTA determination methods. The elaborated method was used for analysis of Latvian market coffee samples. The main parameters of the method (selectivity, linearity, matrix effect, precision and repeatability) were validated and detection and quantification limits were assessed